Amyotrophic Lateral Sclerosis Treatment Market Research and Forecast 2020-2026
A full report of Amyotrophic Lateral Sclerosis Treatment Market is available at: https://www.omrglobal.com/industry-reports/amyotrophic-lateral-sclerosis-treatment-market
Similarly, the people aged over 80 years or older are expected to get quadrupled to 395 million from 2000 to 2050. According to the UN, over the next 15 years, the older population is expected to grow fastest in the Caribbean and Latin America with a projected 71.0% increase in the population aged 60 years or over, followed by Asia (66.0%), Africa (64.0%), Oceania (47.0%), Northern America (41.0%), and Europe (23.0%). In 2018, the global average geriatric population was 8.92%, in which, the percentage of geriatric population in developed economies was much higher than that of the global average (8.92%). In 2018, among the total population, the geriatric population accounted for 16.0% in North America, 22.0% in Germany, 23.0% in Italy, and 27.0% in Japan, among others.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market
The increasing prevalence of amyotrophic lateral sclerosis disorder along with the growing geriatric population which is more susceptible to this kind of disorders are expected to be key factors promoting the growth of the global amyotrophic lateral sclerosis treatment market. Mitsubishi Tanabe Pharma Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., CORESTEM, Inc., BrainStorm Cell Ltd., Otsuka Pharmaceutical Co., Ltd., AB Science, Ionis Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., and so on are the key players operating in the global amyotrophic lateral sclerosis treatment industry.
Recent Development in Amyotrophic Lateral Sclerosis Treatment Market
In September 2018, ITF Pharma, a US-based pharmaceutical company had received the US FDA approval for TIGLUTIK (riluzole). The TIGLUTIK (riluzole) is an oral suspension for the treatment of amyotrophic lateral sclerosis. TIGLUTIK is the first and only easy-to-swallow thickened riluzole liquid for treatment of amyotrophic lateral sclerosis and is advised to intake twice daily via an oral syringe.
Global Amyotrophic Lateral Sclerosis Market Segmentation
• Stem Cell Therapy
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/amyotrophic-lateral-sclerosis-treatment-market
Global Amyotrophic Lateral Sclerosis Market – Segment by Region
• United States
• United Kingdom
• Rest of Europe
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
• AB Science
• Ascend Laboratories LLC
• Biogen Inc.
• Biohaven Pharmaceutical Holding Company Ltd.
• BrainStorm Cell Ltd.
• CORESTEM, Inc
• F.Hoffmann-La Roche AG
• Ionis Pharmaceuticals, Inc.
• ITF Pharma
• Mitsubishi Tanabe Pharma Corp.
• Mylan N.V.
• Otsuka Pharmaceutical Co., Ltd.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Amyotrophic Lateral Sclerosis Treatment Market Research and Forecast 2020-2026 here
News-ID: 2204550 • Views: 315
More Releases from Orion Market Research
Veterinary Dental Equipment Market Trends, Size, Share and Forecast 2023-2029
The global veterinary dental equipment market is anticipated to grow at a CAGR of 6.8% during the forecast period. The increasing companion animals adoption in major economies and rising cases of gum diseases among them is the key factor driving global veterinary dental equipment market. According to the 2019-2020 survey conducted by American Pet Products Association (APPA) on pet ownership, in the US 67.0% of the households are registered as
Veterinary Antimicrobial Susceptibility Testing Market Analysis and Forecast 202 …
The global veterinary antimicrobial susceptibility testing market is anticipated to grow at a considerable CAGR of 6.0% during the forecast period. The increasing pervasiveness of zoonotic diseases is one of the prime factors driving the market. The diseases and infections are generally transmitted between people and vertebrate animals that are divided into classes such as endemic zoonoses, epidemic zoonoses along with emerging and re-emerging zoonoses. This zoonotic disease is increasing
Surgical Instrument Tracking Systems Market Share, Trends, Analysis and Forecast …
The global surgical instrument tracking system market is anticipated to grow at a considerable CAGR of 15.5% during the forecast period. The key driver in the surgical instruments tracking system market is the rapid adoption of healthcare IT in hospitals. Tracking of surgical devices is improving the quality of patient's care procedures, which has become one of the most important aspects in the healthcare service sector. According to the Xerafy,
Surgical Blades & Scalpels Market Share, Trends, Analysis and Forecast 2023-2029
The global surgical blades & scalpels market is anticipated to grow at CAGR of 9.5% during the forecast period. The high prevalence of chronic diseases is a major driving factor that is stimulating number of cardiac surgeries globally. According to the World Health Organization (WHO), every year around 41 million people die with noncommunicable diseases (NCDs). Chronic disease, such as heart attack, stroke, cancer, and respiratory problems are the major
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications